chevron_right About Austrade
Find out about Austrade, the Australian Government’s international trade promotion, investment and visitor attraction agency.
chevron_right How we can help you
Austrade provides programs, insights and advice to help exporters, investors, the education sector and tourism.
chevron_right News and analysis
Browse the latest Austrade news, analysis and publications. Explore timely stories about export, education, investment and other trade-related topics.
chevron_right Events
Explore our webinars, seminars, international tradeshows, and other Austrade events in Australia and around the world.
chevron_right Contact us
See contact details for Austrade. Make an enquiry about grants, exporting and foreign investment. Provide feedback on our services and website.
chevron_right Careers at Austrade
Austrade offers great careers for people with a range of skills in Australia and overseas. Find out about what benefits we offer, how we recruit, and search for current vacancies.
arrow_back
Latest initiatives, success stories, sector and market news, trade and visitor economy updates.
You can stay up to date by subscribing to our email newsletters.
Showing all recent news articles
8 News articles
7 November 2024
360biolabs’ bioanalytical services are supporting clinical trials for global biotech and pharmaceutical clients.
13 August 2024
Australia’s Icon Group has opened its first cancer care centre in Malaysia.
5 June 2024
Nucleus Network is taking its Phase I and first-in-human clinical trial expertise to US, Europe and Asia.
30 May 2023
Leading cell manufacturing facility, Q-Gen Cell Therapeutics, has its sights set on Asia and America as its international reputation continues to grow beyond Australia.
28 March 2023
Agility and innovation help Linear Clinical Research become one of Australia’s leading providers of clinical trials.
1 June 2022
Australian biologics manufacturer BioCina is partnering with Cytiva and the University of Adelaide to manufacture the next generation of mRNA-based therapies.
31 May 2022
AdAlta has pioneered a new technology to generate a new class of antibody protein therapeutics.
Clinical trials conducted by the Sydney Children’s Hospitals Network (SCHN) have led to a life-changing treatment for children with Spinal Muscular Atrophy (SMA).
Austrade experts share their insights and analysis for Australian business. Read our latest commentary articles on trade-related topics.
Contact Austrade’s media team or browse areas of expertise our spokespeople can speak about.
Austrade publications and reports on export and investment opportunities, and corporate reports such as annual reports and corporate plans.
Share this link via
Or copy link